0 Valutazioni
ID

42091

Descrizione

Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form is for logging, if any concomitant medication, (non-)serious adverse events, blood (supportive care) products or additional scans occurred during the study.

collegamento

https://clinicaltrials.gov/ct2/show/NCT00811733

Keywords

versioni (2)
  1. 30/03/21 30/03/21 -
  2. 07/04/21 07/04/21 -
Titolare del copyright

GlaxoSmithKline

Caricato su

7 aprile 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733

    Inglese

    Log Status

    1 moduli  
    1. StudyEvent: ODM
      1. Log Status
    Administrative Data
    Descrizione

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722 (Administrative documentation)
    SNOMED
    405624007
    date of visit/assessment
    Descrizione

    date of visit/assessment

    Tipo di dati

    date

    Alias
    UMLS CUI [1]
    C1320303 (Date of visit)
    SNOMED
    406543005
    UMLS CUI [2]
    C2985720 (Assessment Date)
    subject number
    Descrizione

    subject ID

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Log Status
    Descrizione

    Log Status

    Alias
    UMLS CUI-1
    C1708728 (Event Log)
    UMLS CUI-2
    C0449438 (Status)
    SNOMED
    263490005
    LOINC
    LP73412-6
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    Descrizione

    Concomitant medication taken prior to screening and/or during study

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0332152 (Before)
    SNOMED
    236874000
    UMLS CUI [1,3]
    C0220908 (Screening procedure)
    SNOMED
    20135006
    LOINC
    LP34059-3
    UMLS CUI [2,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [2,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [2,3]
    C2347804 (Clinical Trial Period)
    Did the subject experience any non-serious adverse events during the study?
    Descrizione

    Non-serious adverse events during study

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C1518404 (Non-serious Adverse Event)
    UMLS CUI [1,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [1,3]
    C2347804 (Clinical Trial Period)
    Did the subject experience a serious adverse event during the study?
    Descrizione

    Serious adverse event during study

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C1519255 (Serious Adverse Event)
    UMLS CUI [1,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [1,3]
    C2347804 (Clinical Trial Period)
    Were any blood products / blood supportive care products taken by the subject during the study?
    Descrizione

    Blood products / blood supportive care products taken during study

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0456388 (Blood product)
    SNOMED
    410652009
    LOINC
    LP32808-5
    UMLS CUI [1,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [1,3]
    C2347804 (Clinical Trial Period)
    UMLS CUI [2,1]
    C0018938 (Hematologic Agents)
    SNOMED
    373708006
    UMLS CUI [2,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [2,3]
    C2347804 (Clinical Trial Period)
    Were any other/additional scans performed
    Descrizione

    Other/additional scans performed

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0205394 (Other)
    SNOMED
    74964007
    LOINC
    LP21049-9
    UMLS CUI [1,2]
    C0011923 (Diagnostic Imaging)
    SNOMED
    363679005
    UMLS CUI [2,1]
    C1524062 (Additional)
    LOINC
    LP35025-3
    UMLS CUI [2,2]
    C0011923 (Diagnostic Imaging)
    SNOMED
    363679005
    Ritorna all'inizio della pagina

    Similar models

    Log Status

    1 moduli
    1. StudyEvent: ODM
      1. Log Status
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    date of visit/assessment
    Item
    date of visit/assessment
    date
    C1320303 (UMLS CUI [1])
    C2985720 (UMLS CUI [2])
    subject ID
    Item
    subject number
    text
    C2348585 (UMLS CUI [1])
    Item Group
    Log Status
    C1708728 (UMLS CUI-1)
    C0449438 (UMLS CUI-2)
    Item
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    text
    C2347852 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C0220908 (UMLS CUI [1,3])
    C2347852 (UMLS CUI [2,1])
    C0347984 (UMLS CUI [2,2])
    C2347804 (UMLS CUI [2,3])
    Concomitant medication taken prior to screening and/or during study
    Code List
    Were any concomitant medications taken by the subject prior to screening and/or during the study?
    CL Item
    yes (y)
    CL Item
    no (n)
    Item
    Did the subject experience any non-serious adverse events during the study?
    text
    C1518404 (UMLS CUI [1,1])
    C0347984 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Concomitant medication taken prior to screening and/or during study
    Code List
    Did the subject experience any non-serious adverse events during the study?
    CL Item
    yes (y)
    CL Item
    no (n)
    Item
    Did the subject experience a serious adverse event during the study?
    text
    C1519255 (UMLS CUI [1,1])
    C0347984 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Concomitant medication taken prior to screening and/or during study
    Code List
    Did the subject experience a serious adverse event during the study?
    CL Item
    yes (y)
    CL Item
    no (n)
    Item
    Were any blood products / blood supportive care products taken by the subject during the study?
    text
    C0456388 (UMLS CUI [1,1])
    C0347984 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    C0018938 (UMLS CUI [2,1])
    C0347984 (UMLS CUI [2,2])
    C2347804 (UMLS CUI [2,3])
    Concomitant medication taken prior to screening and/or during study
    Code List
    Were any blood products / blood supportive care products taken by the subject during the study?
    CL Item
    yes (y)
    CL Item
    no (n)
    Item
    Were any other/additional scans performed
    text
    C0205394 (UMLS CUI [1,1])
    C0011923 (UMLS CUI [1,2])
    C1524062 (UMLS CUI [2,1])
    C0011923 (UMLS CUI [2,2])
    Concomitant medication taken prior to screening and/or during study
    Code List
    Were any other/additional scans performed
    CL Item
    yes (y)
    CL Item
    no (n)
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial